Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U Share Card Has Best Prices On Pfizer, Lilly Brands In Latest Medicare Data

This article was originally published in The Pink Sheet Daily

Executive Summary

The "U Share" Medicare-endorsed discount card is offering the lowest prices on most Pfizer and Lilly prescription drug brands, according to updated pricing data posted on the Centers for Medicare & Medicaid Services website May 17
Advertisement

Related Content

Pfizer "Helpful Answers" Initiative Expands Free Rx Program
Pfizer "Helpful Answers" Initiative Expands Free Rx Program
“U Share” Cuts Mail Order Prices For Pfizer Drugs: Medicare Discount Update
“U Share” Cuts Mail Order Prices For Pfizer Drugs: Medicare Discount Update
Pharmacy Care Alliance Medicare Card On Track To Enroll 250,000 Seniors, Express Scripts Says
Pharmacy Care Alliance Medicare Card On Track To Enroll 250,000 Seniors, Express Scripts Says
Medicare Card Enrollment Is “Many Thousands,” McClellan Says; CMS Call Center Adding 1,000 Reps
Medicare Card Enrollment Is “Many Thousands,” McClellan Says; CMS Call Center Adding 1,000 Reps

Topics

Advertisement
UsernamePublicRestriction

Register

PS059434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel